Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastasis Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00817362
What this trial is testing

Efficacy and Safety of IPI-504 With Trastuzumab Pretreated, Locally Advanced or Metastatic HER2 Positive Breast Cancer

Who this might be right for
Breast CancerHER2 Positive Breast CancerMetastatic Breast Cancer+1 more
Infinity Pharmaceuticals, Inc. 29
Large-scale testing (Phase 3)UnknownNCT00532727
What this trial is testing

Triple Negative Breast Cancer Trial

Who this might be right for
Breast Cancer
Institute of Cancer Research, United Kingdom 400
Large-scale testing (Phase 3)Active Not RecruitingNCT05382286
What this trial is testing

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer

Who this might be right for
Triple Negative Breast CancerPD-L1 Positive
Gilead Sciences 443
Early research (Phase 1)Active Not RecruitingNCT05143970
What this trial is testing

First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid Tumors

Who this might be right for
Metastatic CancerMetastatic Breast CancerMetastatic Pancreatic Cancer+6 more
Institut Paoli-Calmettes 27
Testing effectiveness (Phase 2)Looking for participantsNCT05318469
What this trial is testing

Ivermectin in Combination With Balstilimab or Pembrolizumab in Patients With Metastatic Triple Negative Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Triple-Negative Breast Carcinoma
Yuan Yuan 34
Not applicableActive Not RecruitingNCT05529862
What this trial is testing

Trans-RosaLEE Study: a Biomarker-directed, Translational Study

Who this might be right for
Advanced or Metastatic Breast Cancer (BC)
Institut Paoli-Calmettes 115
Not applicableLooking for participantsNCT07252986
What this trial is testing

Clinical Translation Research on a Multi-omics Breast Cancer Distant Metastasis Prediction Model Empowered by Artificial Intelligence

Who this might be right for
BreastBreast CancerPathology
Second Affiliated Hospital, Zhejiang University, School of Medicine 2,000
Testing effectiveness (Phase 2)Study completedNCT01738438
What this trial is testing

Cabozantinib for Metastatic Triple Negative BrCa

Who this might be right for
Breast Cancer
Dana-Farber Cancer Institute 35
Testing effectiveness (Phase 2)Ended earlyNCT00470249
What this trial is testing

Carboplatin and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
University of Southampton 5
Testing effectiveness (Phase 2)Study completedNCT00615940
What this trial is testing

Combination of Oral WX-671 Plus Capecitabine vs. Capecitabine Monotherapy in First-line Her2-negative Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Heidelberg Pharma AG 132
Not applicableActive Not RecruitingNCT04497285
What this trial is testing

Real World Study Using Comprehensive Genomic Data on the Next Treatment Decision Making in Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
SOLTI Breast Cancer Research Group 600
Testing effectiveness (Phase 2)UnknownNCT04061408
What this trial is testing

FSRT in Breast Cancer Patients With Brain Metastases

Who this might be right for
Breast CancerBrain Metastases
Fudan University 170
Early research (Phase 1)Study completedNCT01471847
What this trial is testing

A Phase Ib/II Study of BEZ235 and Trastuzumab in Patients With HER2-positive Breast Cancer Who Failed Prior to Trastuzumab

Who this might be right for
Locally Advance Breast Cancer (LABC)Metastatic Breast Cancer (MBC)
Novartis Pharmaceuticals 5
Testing effectiveness (Phase 2)Looking for participantsNCT05816655
What this trial is testing

Comparison of Clinical Efficacy Between Letrozole + Ribociclib and Fulvestrant + Letrozole + Ribociclib in Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Korea University Guro Hospital 202
Testing effectiveness (Phase 2)Study completedNCT01025349
What this trial is testing

Salvage Therapy With Bevacizumab Plus Docetaxel and Cisplatin for Taiwanese Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Taipei Medical University Hospital 20
Early research (Phase 1)WithdrawnNCT04332549
What this trial is testing

To Assess the Bioavailability and Safety of Paclitaxel Injection Concentrate for Suspension in Subjects With Locally Recurrent or Metastatic Breast Cancer

Who this might be right for
Metastatic Breast CancerLocally Recurrent Cancer
Sun Pharma Advanced Research Company Limited
Early research (Phase 1)Ended earlyNCT04315233
What this trial is testing

Ribociclib&Belinostat In Patients w Metastatic Triple Neg Breast Cancer & Recurrent Ovarian Cancer w Response Prediction By Genomics

Who this might be right for
Metastatic Breast CancerRecurrent Ovarian Carcinoma
University of Utah 12
Post-approval studies (Phase 4)UnknownNCT03591549
What this trial is testing

Fulvestrant in Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Assiut University 30
Large-scale testing (Phase 3)Study completedNCT05629949
What this trial is testing

A Multicenter, Double-blind, Randomized, Parallel-group, Phase III Study of the Efficacy and Safety of QL1701 Plus Docetaxel Versus Herceptin® Plus Docetaxel as First Line Therapy in Patients With HER2-positive Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Qilu Pharmaceutical Co., Ltd. 474
Not applicableNot Yet RecruitingNCT07521826
What this trial is testing

Exercise Training in Women With Metastatic Breast Cancer

Who this might be right for
CancerMetastases
State University of Londrina 78
Next Page